Skip to Content

ZA 66 125 mg (Divalproex Sodium Delayed-Release (Sprinkle) 125 mg)

Pill with imprint ZA 66 125 mg is Blue & White, Capsule-shape and has been identified as Divalproex sodium delayed-release (sprinkle) 125 mg. It is supplied by Zydus Pharmaceuticals.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for ZA 66 125 mg

Divalproex sodium delayed-release (sprinkle)

ZA 66 125 mg
125 mg
Blue & White
22.00 mm
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Zydus Pharmaceuticals
Inactive Ingredients:
FD&C Blue No. 1
silicon dioxide
triethyl citrate
methacrylic acid
sodium lauryl sulfate
magnesium silicate
titanium dioxide
microcrystalline cellulose
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0313 Amerisource Health Services

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.